Unknown PHASE4 INTERVENTIONAL 4-arm NCT00674921

Cotrimoxazole Prophylaxis Cessation Study Among Stabilized HIV-Infected Adult Patients on HAART in Entebbe, Uganda (CCS)

Sponsor: MRC/UVRI and LSHTM Uganda Research Unit

Updated 7 times since 2017 Last updated: Jun 4, 2008 Started: Jun 30, 2008 Primary completion: Jun 30, 2011 Completion: Jun 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00674921, this PHASE4 trial focuses on HIV Infections and remains ongoing. Sponsored by MRC/UVRI and LSHTM Uganda Research Unit, it has been updated 7 times since 2008, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Oct 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jan 2021 — Oct 2021 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Unknown Status PHASE4
Jan 2017 — Feb 2017 [monthly]

Unknown Status PHASE4

First recorded

Jun 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

MRC/UVRI and LSHTM Uganda Research Unit
Medical Research Council

Data source: MRC/UVRI and LSHTM Uganda Research Unit

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Entebbe, Uganda